Command Palette

Search for a command to run...

Unick Fix-A-Form And Printers Ltd.
65(+0.00%)
1W: +3.17%

Unick Fix-A-Form And Printers Peer Comparison

Snapshot Summary

Unick Fix-A-Form And Printers Ltd. currently exhibits weak financial metrics, with no growth, profitability, or efficiency, leading to an unfavorable comparison with its peers in the Pharmaceuticals & Drugs sector. Companies like Sun Pharmaceutical Industries Ltd. and Dr. Reddy's Laboratories Ltd. stand out as strong performers, showcasing robust profitability and growth, while Unick's lack of revenue and EPS growth marks it as an underperformer in this competitive landscape.

  • Unick has no revenue or EPS growth, placing it at a disadvantage compared to peers.
  • Sun Pharmaceutical and Dr. Reddy's Laboratories are sector leaders with strong profitability and growth metrics.
  • Cipla and Mankind Pharma show promising growth with reasonable valuation metrics.
  • Sun Pharmaceutical Industries Ltd.: Highest profitability metrics with strong revenue and EPS growth.
  • Dr. Reddy's Laboratories Ltd.: Consistent growth in revenue and EPS, along with strong returns and low debt.
  • Cipla Ltd.: Good balance of growth and valuation attractiveness.
  • Mankind Pharma Ltd.: High revenue growth trajectory with solid profitability.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Unick Fix-A-Form And Printers Ltd.₹71.00₹38.94Cr14.92--
SUNPHARMA₹1,563.35₹3,75,099.26Cr87.5917.60%0.04
DIVISLAB₹6,091.05₹1,61,698.50Cr73.2016.46%-
CIPLA₹1,587.60₹1,28,217.27Cr23.7322.77%0.01
TORNTPHARM₹3,581.55₹1,21,215.77Cr61.5324.28%0.57
DRREDDY₹1,280.30₹1,06,835.27Cr15.5026.86%0.07
MANKIND₹2,518.95₹1,03,926.59Cr55.1828.38%0.02

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.